Fennec Pharmaceuticals Inc

Fennec CEO Settles 13,710 PSUs, Signaling Confidence as Share Price Climbs Past 52‑Week High

CEO Jeffrey Hackman’s recent 13,710‑share purchase signals growing confidence in Fennec Pharmaceuticals, amid a 7% weekly rally and strong insider buying.

Fennec Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

20/02/2026, 01:00

4 minutes to read

CFO of Fennec Pharmaceuticals Buys More Shares Amid Market Dip, Reinforcing Long‑Term Confidence

Fennec Pharmaceuticals CFO’s latest insider buy signals long‑term confidence, hinting at a potential rebound amid market volatility and a strong oncology pipeline.

Fennec Pharmaceuticals Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

07/01/2026, 22:43

3 minutes to read